1. Home
  2. ATCH vs CMND Comparison

ATCH vs CMND Comparison

Compare ATCH & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATCH
  • CMND
  • Stock Information
  • Founded
  • ATCH 2022
  • CMND 2017
  • Country
  • ATCH United States
  • CMND Canada
  • Employees
  • ATCH N/A
  • CMND N/A
  • Industry
  • ATCH
  • CMND Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATCH
  • CMND Health Care
  • Exchange
  • ATCH Nasdaq
  • CMND Nasdaq
  • Market Cap
  • ATCH 5.2M
  • CMND 5.3M
  • IPO Year
  • ATCH N/A
  • CMND N/A
  • Fundamental
  • Price
  • ATCH $0.21
  • CMND $1.20
  • Analyst Decision
  • ATCH
  • CMND
  • Analyst Count
  • ATCH 0
  • CMND 0
  • Target Price
  • ATCH N/A
  • CMND N/A
  • AVG Volume (30 Days)
  • ATCH 1.9M
  • CMND 65.9K
  • Earning Date
  • ATCH 11-15-2024
  • CMND 02-05-2025
  • Dividend Yield
  • ATCH N/A
  • CMND N/A
  • EPS Growth
  • ATCH N/A
  • CMND N/A
  • EPS
  • ATCH 0.04
  • CMND N/A
  • Revenue
  • ATCH N/A
  • CMND N/A
  • Revenue This Year
  • ATCH N/A
  • CMND N/A
  • Revenue Next Year
  • ATCH N/A
  • CMND N/A
  • P/E Ratio
  • ATCH $4.56
  • CMND N/A
  • Revenue Growth
  • ATCH N/A
  • CMND N/A
  • 52 Week Low
  • ATCH $0.12
  • CMND $0.92
  • 52 Week High
  • ATCH $10.26
  • CMND $3.58
  • Technical
  • Relative Strength Index (RSI)
  • ATCH 52.39
  • CMND 43.14
  • Support Level
  • ATCH $0.18
  • CMND $1.26
  • Resistance Level
  • ATCH $0.24
  • CMND $1.53
  • Average True Range (ATR)
  • ATCH 0.02
  • CMND 0.09
  • MACD
  • ATCH -0.00
  • CMND -0.00
  • Stochastic Oscillator
  • ATCH 47.31
  • CMND 6.07

About ATCH AtlasClear Holdings Inc. Common Stock

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: